Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,291) with videos related to
Page
of 130
Sort By:
Leukemia
|
August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, et al.
Blood
|
March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
Nicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Leukemia
|
October 15, 2015
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
A Gratwohl, M Pfirrmann, A Zander, et al.
Haematologica
|
December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Christian Michel, Andreas Burchert, Andreas Hochhaus, et al.
The Lancet. Haematology
|
October 14, 2019
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Dietrich Wilhelm Beelen, Rudolf Trenschel, Matthias Stelljes, et al.
Cell
|
May 26, 2015
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
Tongqing Zhou, Rebecca M Lynch, Lei Chen, et al.
Science (New York, N.Y.)
|
November 30, 2019
Lactose drives <i>Enterococcus</i> expansion to promote graft-versus-host disease
C K Stein-Thoeringer, K B Nichols, A Lazrak, et al.
Leukemia
|
August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann, M Lauseker, S Saußele, et al.
Molecular Psychiatry
|
April 5, 2017
Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression
R C Culverhouse, N L Saccone, A C Horton, et al.
Science (New York, N.Y.)
|
December 24, 2010
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project
Mark B Gerstein, Zhi John Lu, Eric L Van Nostrand, et al.
Page
of 130
Search research articles
Search
Showing results (1241-1250 of 1,291) with videos related to
Sort By:
Page
of 130
Leukemia
|
August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, et al.
Blood
|
March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
Nicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Leukemia
|
October 15, 2015
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
A Gratwohl, M Pfirrmann, A Zander, et al.
Haematologica
|
December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Christian Michel, Andreas Burchert, Andreas Hochhaus, et al.
The Lancet. Haematology
|
October 14, 2019
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Dietrich Wilhelm Beelen, Rudolf Trenschel, Matthias Stelljes, et al.
Cell
|
May 26, 2015
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
Tongqing Zhou, Rebecca M Lynch, Lei Chen, et al.
Science (New York, N.Y.)
|
November 30, 2019
Lactose drives <i>Enterococcus</i> expansion to promote graft-versus-host disease
C K Stein-Thoeringer, K B Nichols, A Lazrak, et al.
Leukemia
|
August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann, M Lauseker, S Saußele, et al.
Molecular Psychiatry
|
April 5, 2017
Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression
R C Culverhouse, N L Saccone, A C Horton, et al.
Science (New York, N.Y.)
|
December 24, 2010
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project
Mark B Gerstein, Zhi John Lu, Eric L Van Nostrand, et al.
Page
of 130